Correlation Between Krebs Biochemicals and Biofil Chemicals

Can any of the company-specific risk be diversified away by investing in both Krebs Biochemicals and Biofil Chemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krebs Biochemicals and Biofil Chemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Krebs Biochemicals and and Biofil Chemicals Pharmaceuticals, you can compare the effects of market volatilities on Krebs Biochemicals and Biofil Chemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krebs Biochemicals with a short position of Biofil Chemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krebs Biochemicals and Biofil Chemicals.

Diversification Opportunities for Krebs Biochemicals and Biofil Chemicals

-0.12

Correlation Coefficient

Krebs Biochemicals  Biofil Chemicals

Good diversification

The 3 months correlation between Krebs and Biofil is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Krebs Biochemicals and and Biofil Chemicals Pharmaceutica in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biofil Chemicals Pha and Krebs Biochemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krebs Biochemicals and are associated (or correlated) with Biofil Chemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biofil Chemicals Pha has no effect on the direction of Krebs Biochemicals i.e., Krebs Biochemicals and Biofil Chemicals go up and down completely randomly.

Pair Corralation between Krebs Biochemicals and Biofil Chemicals

Assuming the 90 days trading horizon Krebs Biochemicals and is expected to generate 1.08 times more return on investment than Biofil Chemicals. However, Krebs Biochemicals is 1.08 times more volatile than Biofil Chemicals Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Biofil Chemicals Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest  8,246  in Krebs Biochemicals and on September 3, 2024 and sell it today you would earn a total of  2,168  from holding Krebs Biochemicals and or generate 26.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Krebs Biochemicals and  vs.  Biofil Chemicals Pharmaceutica

Krebs Biochemicals and

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Biofil Chemicals Pha

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Biofil Chemicals Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical indicators, Biofil Chemicals is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Krebs Biochemicals and Biofil Chemicals

The main advantage of trading using opposite Krebs Biochemicals and Biofil Chemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krebs Biochemicals position performs unexpectedly, Biofil Chemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofil Chemicals will offset losses from the drop in Biofil Chemicals' long position.

The idea behind Krebs Biochemicals and and Biofil Chemicals Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..